oxazoles has been researched along with bmy 42393 in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (76.92) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brassard, CL; Buchanan, JO; Federici, ME; Fleming, JS; Gamberdella, M; Hartl, KS; Meanwell, NA; Rosenfeld, MJ; Trehan, AK; Wright, JJ | 1 |
Jones, RL; Qian, YM; Wise, H | 1 |
Brassard, CL; Buchanan, JO; Federici, ME; Fleming, JS; Meanwell, NA; Seiler, SM; Zavoico, GB | 1 |
Buchanan, JO; Fleming, JS; Gamberdella, M; Meanwell, NA; Schumacher, WA; Seiler, SM; Zavoico, GB | 1 |
Abid, S; Grove, RI; Hartl, KS; Kowala, MC; Mazzucco, CE; Seiler, SM; Warr, GA | 1 |
Wise, H | 2 |
Brassard, CL; Federici, ME; Meanwell, NA; Romine, J; Seiler, SM | 1 |
Chan, HW; Ho, JK; Jones, RL; Lam, WL; Qian, YM; Wise, H; Wong, HN; Yim, AP | 1 |
Chow, KB; Wise, H | 1 |
Jones, RL; Qian, Ym; Rudd, JA; Tsui, KK | 1 |
Chow, KB; Kam, Y; Wise, H | 1 |
Chow, KB; Wise, H; Wong, YH | 1 |
13 other study(ies) available for oxazoles and bmy 42393
Article | Year |
---|---|
Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ring.
Topics: Cell Membrane; Humans; Iloprost; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1994 |
A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors.
Topics: Acetates; Amino Acid Sequence; Animals; Bridged Bicyclo Compounds; Cell Aggregation; Colon; Cyclohexanols; Drug Interactions; Epoprostenol; In Vitro Techniques; Male; Molecular Sequence Data; Muscle Contraction; N-Formylmethionine Leucyl-Phenylalanine; Neurons; Neutrophils; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Receptors, Prostaglandin; Stimulation, Chemical | 1995 |
2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
Topics: Adenylyl Cyclases; Blood Platelets; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Epoprostenol; Humans; Molecular Structure; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Radioligand Assay; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship | 1994 |
2-[3-[2-(4,5-diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): 2). Oral activity and efficacy in animal models of arterial thrombosis.
Topics: Administration, Oral; Animals; Chlorocebus aethiops; Coronary Thrombosis; Disease Models, Animal; Dogs; Humans; Macaca fascicularis; Male; Oxazoles; Phenoxyacetates; Rabbits; Rats; Rats, Sprague-Dawley; Renal Artery Obstruction | 1994 |
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Chemotaxis; Cholesterol Esters; Cricetinae; Epoprostenol; Hyperlipidemias; Imidazoles; Macrophages; Male; Membrane Proteins; Monocytes; Oxazoles; Phenoxyacetates; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Tumor Necrosis Factor-alpha | 1993 |
The inhibitory effects of non-prostanoid prostacyclin mimetics on rat neutrophil function.
Topics: Acetates; Animals; Calcium; Cell Aggregation; Cyclic AMP; Drug Design; Epoprostenol; Glyburide; Iloprost; Imidazoles; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Phenoxyacetates; Phosphodiesterase Inhibitors; Prostaglandins, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin | 1996 |
[3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
Topics: Acetates; Adenylyl Cyclases; Animals; Binding, Competitive; Cell Membrane; Cyclic AMP; Epoprostenol; GTP Phosphohydrolases; Humans; Iloprost; Imidazoles; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Protein Kinases; Rabbits; Rats | 1997 |
Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
Topics: Acetates; Aged; Cardiovascular Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Fatty Acids; Humans; Iloprost; Imidazoles; Indoles; Middle Aged; Muscle, Smooth, Vascular; Oxazoles; Phenoxyacetates; Platelet Aggregation Inhibitors; Prostaglandins, Synthetic; Pulmonary Artery; Receptors, Epoprostenol; Receptors, Prostaglandin; Structure-Activity Relationship; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
The effect of prostacyclin mimetics on neutrophil function.
Topics: Acetates; Animals; Cell Aggregation; Cyclic AMP; Epoprostenol; Iloprost; Imidazoles; Isoquinolines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxazoles; Peritoneal Cavity; Phenoxyacetates; Pyrrolidinones; Rats; Rolipram; Second Messenger Systems; Sulfonamides | 1997 |
The effect of non-prostanoid prostacyclin mimetics on cyclic AMP production by neuronal SK-N-SH cells.
Topics: Acetates; Cell Line; Cyclic AMP; Epoprostenol; Humans; Iloprost; Imidazoles; Kinetics; Neuroblastoma; Neurons; Oxazoles; Phenoxyacetates | 1997 |
Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.
Topics: Acetates; Animals; Colon; Epoprostenol; In Vitro Techniques; Male; Molecular Mimicry; Neuromuscular Depolarizing Agents; Neuromuscular Junction; Oxazoles; Phenoxyacetates; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Epoprostenol; Receptors, Prostaglandin; Vagus Nerve | 2000 |
Factors affecting prostacyclin receptor agonist efficacy in different cell types.
Topics: Acetates; Adenylate Cyclase Toxin; Animals; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Epoprostenol; Heterotrimeric GTP-Binding Proteins; Humans; Imidazoles; Oxazoles; Pertussis Toxin; Phenoxyacetates; Receptors, Epoprostenol; Receptors, Prostaglandin; Signal Transduction; Tumor Cells, Cultured; Type C Phospholipases; Virulence Factors, Bordetella | 2001 |
Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
Topics: Acetates; Adenylyl Cyclases; Alprostadil; Animals; Cell Survival; CHO Cells; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoprostenol; Iloprost; Imidazoles; Inositol Phosphates; Oxazoles; Phenoxyacetates; Pyridines; Receptors, Epoprostenol; Receptors, Prostaglandin; Transfection; Tritium; Type C Phospholipases | 2001 |